Sino Biopharmaceutical (SBMFF) Income Statement
Sino Biopharmaceutical Income Statement
Last quarter (Q2 2026), Sino Biopharmaceutical's total revenue was $9.72B, an increase of 10.64% from the same quarter last year. In Q2, Sino Biopharmaceutical's net income was $1.72B. See Sino Biopharmaceutical’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 31.83B | $ 28.87B | $ 26.20B | $ 26.03B | $ 26.86B | |
| $ 26.13B | $ 23.53B | $ 21.21B | $ 21.54B | $ 21.53B | |
| $ 19.17B | $ 17.39B | $ 15.54B | $ 15.95B | $ 16.45B | |
| Depreciation and Amortization | $ 1.21B | $ 1.32B | $ 1.07B | $ 1.05B | $ 992.56M |
| $ 7.50B | $ 6.49B | $ 6.98B | $ 6.69B | $ 19.87B | |
| $ 6.95B | $ 6.14B | $ 5.67B | $ 5.59B | $ 5.16B | |
| $ -10.21M | $ -858.09M | $ -259.97M | $ -370.95M | $ 13.49B | |
| $ 6.94B | $ 5.28B | $ 5.41B | $ 5.21B | $ 18.57B | |
| $ 2.34B | $ 3.50B | $ 2.33B | $ 2.54B | $ 14.61B | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.13 | $ 0.10 | $ 0.10 | $ 0.11 | $ 0.78 |
| Diluted EPS | $ 0.13 | $ 0.10 | $ 0.10 | $ 0.12 | $ 0.73 |
| Weighted Average Shares Outstanding | 18.05B | 17.24B | 18.53B | 18.62B | 18.77B |
| Weighted Average Shares Outstanding (Diluted) | 18.06B | 18.30B | 18.53B | 19.02B | 19.28B |
Currency in CNY